London-Based Cori Clinical Secures €3.56 Mn to Accelerate Clinical Trials

The funding round was led by Breega, with participation from Enzo, Heartfelt, Together Ventures, and Bynd.

Cori Clinical will use the new funding to increase its delivery capacity and grow its team. The company has also appointed Dr. Emma Ogburn as Chief Clinical Officer. She joins Cori Clinical from Lindus Health. The startup also plans to strengthen the regulatory and clinical intelligence built into its platform.

Jorn Jansen Schoonhoven, co-founder and CEO of Cori Clinical, said, “Clinical trials are built through a series of interconnected decisions about how a study should be designed and run. Today, much of the knowledge and precedent behind those decisions is scattered across previous trials, siloed teams, internal systems and separate documents. Cori brings that intelligence together into a living blueprint, so teams can make better-informed decisions before avoidable problems become delays, so the science never waits on the process.”

Matthieu Vallin, Partner at Breega, which led the funding round, said, “Clinical trial start-up is a critical but often overlooked bottleneck in drug development, with months lost between designing a trial and enrolling the first patient. Cori is bringing the intelligence and connected workflows needed to make that process faster, and we’re excited to back Jorn, Patricio and Emma and the team as they bring this powerful capability to more trials”.

Founded in 2025 by Schoonhoven and Patricio Fernández, Cori Clinical helps clinical teams plan and manage trials from the early idea stage through execution.

Its platform brings together the team’s knowledge, experience and trusted external information in one shared workspace. This gives clinical and commercial teams a single place to work with important trial information.

The platform helps teams identify potential risks, compare different options and connect the study design with the practical needs of running a clinical trial.

Read Also- Antseed Raises $2.4 Mn to Build an Open Marketplace for AI Inference